Nyxoah (NYXH) Research & Development (2021 - 2026)
Nyxoah (NYXH) posted quarterly Research & Development of -$10307.2 for Q1 2026, down 9.01% year-over-year from -$11327.8 in Q1 2025, and down 100.0% quarter-over-quarter from $12.6 billion in Q4 2025.
Nyxoah (NYXH) Research & Development (2021 - 2026) Analysis & Trends
Nyxoah's Research & Development history runs 6 years deep, the most recent figure standing at -$10307.2 for Q1 2026.
- In Q1 2026, Research & Development fell 9.01% year-over-year to -$10307.2; the TTM figure through Mar 2026 stood at $12.6 billion (up 200.37% YoY), while the FY2025 annual figure was $49.8 million, up 35.9% from the prior year.
- Research & Development for Q1 2026 stood at -$10307.2, down from $12.6 billion in the prior quarter.
- The five-year high for Research & Development was $12.6 billion in Q4 2025, with the low at -$12.6 billion in Q4 2024.
- The 5-year median for Research & Development is -$8.0 million (2024), against an average of -$1.6 billion.
- The sharpest annual moves came in 2023 and 2025: Research & Development tumbled 163689.01% in 2023, then soared 200.71% in 2025.
- Nyxoah's Research & Development stood at -$4.7 billion in 2022, then sank by 68.76% to -$7.9 billion in 2023, then sank by 59.43% to -$12.6 billion in 2024, then jumped by 200.71% to $12.6 billion in 2025, then sank by 100.0% to -$10307.2 in 2026.
- Business Quant data shows NYXH's Research & Development at -$10307.2 in Q1 2026, $12.6 billion in Q4 2025, and -$15.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Nyxoah | 90.94 Mn | 90.94 Mn | 5.33 Mn | 11.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.09 Mn |
| Mar 31, 2026 | -10,307.24 |
| Dec 31, 2025 | 12.65 Bn |
| Sep 30, 2025 | -15.09 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Mar 31, 2025 | -9,455.39 |
| Dec 31, 2024 | -12.56 Bn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -8.05 Mn |
| Mar 31, 2024 | -7.82 Bn |
| Dec 31, 2023 | -7.88 Bn |
| Sep 30, 2023 | -7.15 Mn |
| Jun 30, 2023 | -7.19 Mn |
| Mar 31, 2023 | -6.61 Bn |
| Dec 31, 2022 | -4.67 Bn |
| Sep 30, 2022 | -4.26 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | -4.03 Mn |
| Dec 31, 2021 | -3.82 Bn |
| Sep 30, 2021 | -4.15 Mn |